News ARK launches new health comms outfit ARK and Olly Childs have launched a new agency, ARK Comms, to help support the widening needs of its healthcare clients.
News GSK boosts anti-infectives pipeline with Scynexis antifungal Last year, GSK said it was planning to invest a cool £1 billion in infectious d
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
